Pathogenesis of Hypertension: Interactions Among Sodium, Potassium, and Aldosterone

American Journal of Kidney Diseases

Volumn 55, Issue 6, 2010, Pages 1111-1120

  Büssemaker, Eckhart ^a   Hillebrand, Uta ^a   Hausberg, Martin ^b   Pavenstädt, Hermann ^a   Oberleithner, Hans ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; atomic force microscopy; endothelial dysfunction; nitric oxide; spironolactone

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMLODIPINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE; NITRIC OXIDE; POTASSIUM; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CELL STRUCTURE; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HORMONE ACTION; HUMAN; HYPERTENSION; MICROALBUMINURIA; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; POTASSIUM INTAKE; PREVALENCE; SMOOTH MUSCLE TONE; SODIUM BLOOD LEVEL; SODIUM INTAKE; SYSTEMIC CIRCULATION; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ALDOSTERONE; ELASTICITY; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; POTASSIUM; POTASSIUM, DIETARY; SODIUM; SODIUM, DIETARY; VASCULAR RESISTANCE;

EID: 77952541444     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.12.022     Document Type: Article

References (75)

1. Lifton R.P. Genetic determinants of human hypertension. Proc Natl Acad Sci U S A 92 19 (1995) 8545-8551
2. Mullins L.J., Bailey M.A., and Mullins J.J. Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev 86 2 (2006) 709-746
3. Meneton P., Jeunemaitre X., de Wardener H.E., and MacGregor G.A. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85 2 (2005) 679-715
4. Appel L.J., Brands M.W., Daniels S.R., Karanja N., Elmer P.J., and Sacks F.M. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47 2 (2006) 296-308
5. + storage in rats. Am J Physiol Renal Physiol 285 6 (2003) F1108-F1117
6. Titze J., Krause H., Hecht H., et al. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol 283 1 (2002) F134-F141
7. Schiffrin E.L. Effects of aldosterone on the vasculature. Hypertension 47 3 (2006) 312-318
8. Golestaneh N., Klein C., Valamanesh F., Suarez G., Agarwal M.K., and Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 280 5 (2001) 1300-1306
9. Oberleithner H., Ludwig T., Riethmuller C., et al. Human endothelium: target for aldosterone. Hypertension 43 5 (2004) 952-956
10. Chen W., Valamanesh F., Mirshahi T., et al. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul Pharmacol 40 6 (2004) 269-277
11. Oberleithner H., Riethmuller C., Ludwig T., et al. Differential action of steroid hormones on human endothelium. J Cell Sci 119 pt 9 (2006) 1926-1932
12. Safar M.E. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens 23 4 (2005) 673-681
13. Nagata D., Takahashi M., Sawai K., et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 48 1 (2006) 165-171
14. Hashikabe Y., Suzuki K., Jojima T., Uchida K., and Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol 47 4 (2006) 609-613
15. Duffy S.J., Biegelsen E.S., Eberhardt R.T., Kahn D.F., Kingwell B.A., and Vita J.A. Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension 46 4 (2005) 707-713
16. Hamlyn J.M., and Blaustein M.P. Sodium chloride, extracellular fluid volume, and blood pressure regulation. Am J Physiol 251 4 pt 2 (1986) F563-F575
17. He F.J., Markandu N.D., Sagnella G.A., de Wardener H.E., and MacGregor G.A. Plasma sodium: ignored and underestimated. Hypertension 45 1 (2005) 98-102
18. de Wardener H.E., He F.J., and MacGregor G.A. Plasma sodium and hypertension. Kidney Int 66 6 (2004) 2454-2466
19. Kaplan N.M. Primary hypertension: pathogenesis. In: Kaplan N.M. (Ed). Kaplan's Clinical Hypertension (2006), Lippincott Williams & Wilkins, Philadelphia, PA 50-121
20. Adrogue H.J., and Madias N.E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356 19 (2007) 1966-1978
21. Kido M., Ando K., Onozato M.L., et al. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension 51 2 (2008) 225-231
22. He F.J., and MacGregor G.A. Fortnightly review: beneficial effects of potassium. BMJ 323 7311 (2001) 497-501
23. Khaw K.T., and Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 316 5 (1987) 235-240
24. Tobian L., MacNeill D., Johnson M.A., Ganguli M.C., and Iwai J. Potassium protection against lesions of the renal tubules, arteries, and glomeruli and nephron loss in salt-loaded hypertensive Dahl S rats. Hypertension 6 2 pt 2 (1984) I170-I176
25. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 297 6644 (1988) 319-328
26. Dolson G.M., Ellis K.J., Bernardo M.V., Prakash R., and Adrogue H.J. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 26 2 (1995) 321-326
27. Adrogue H.J., and Wesson D.E. Role of dietary factors in the hypertension of African Americans. Semin Nephrol 16 2 (1996) 94-101
28. Krishna G.G., Miller E., and Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 320 18 (1989) 1177-1182
29. Krishna G.G., and Kapoor S.C. Potassium depletion exacerbates essential hypertension. Ann Intern Med 115 2 (1991) 77-83
30. Grim C.E., Luft F.C., Miller J.Z., et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 33 2 (1980) 87-94
31. He F.J., Marciniak M., Visagie E., et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 54 3 (2009) 482-488
32. Pimenta E., Gaddam K.K., Oparil S., et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54 3 (2009) 475-481
33. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 1 (1990) 22-27
34. Fujiwara N., Osanai T., Kamada T., Katoh T., Takahashi K., and Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 101 8 (2000) 856-861
35. Haddy F.J., Vanhoutte P.M., and Feletou M. Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol 290 3 (2006) R546-R552
36. Amberg G.C., Bonev A.D., Rossow C.F., Nelson M.T., and Santana L.F. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112 5 (2003) 717-724
37. Blacher J., Amah G., Girerd X., et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 10 12 pt 1 (1997) 1326-1334
38. Brown N.J. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 14 3 (2005) 235-241
39. Lacolley P., Labat C., Pujol A., Delcayre C., Benetos A., and Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 106 22 (2002) 2848-2853
40. Quaschning T., Ruschitzka F., Shaw S., and Luscher T.F. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension 37 2 pt 2 (2001) 801-805
41. Leopold J.A., Dam A., Maron B.A., et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 13 2 (2007) 189-197
42. Struthers A.D., and MacDonald T.M. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 61 4 (2004) 663-670
43. Abiose A.K., Mansoor G.A., Barry M., Soucier R., Nair C.K., and Hager D. Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. Am J Cardiol 93 12 (2004) 1564-1566
44. Pu Q., Neves M.F., Virdis A., Touyz R.M., and Schiffrin E.L. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42 1 (2003) 49-55
45. Wong S., Brennan F.E., Young M.J., Fuller P.J., and Cole T.J. A direct effect of aldosterone on endothelin-1 gene expression in vivo. Endocrinology 148 4 (2007) 1511-1517
46. Suzuki G., Morita H., Mishima T., et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 106 23 (2002) 2967-2972
47. Pesen D., and Hoh J.H. Micromechanical architecture of the endothelial cell cortex. Biophys J 88 1 (2005) 670-679
48. Pesen D., and Hoh J.H. Modes of remodeling in the cortical cytoskeleton of vascular endothelial cells. FEBS Lett 579 2 (2005) 473-476
49. Davies P.F., Zilberberg J., and Helmke B.P. Spatial microstimuli in endothelial mechanosignaling. Circ Res 92 4 (2003) 359-370
50. Kidoaki S., and Matsuda T. Shape-engineered vascular endothelial cells: nitric oxide production, cell elasticity, and actin cytoskeletal features. J Biomed Mater Res A 81 3 (2007) 728-735
51. Hutcheson I.R., and Griffith T.M. Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release. Br J Pharmacol 118 3 (1996) 720-726
52. Ladage D., Brixius K., Hoyer H., et al. Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol 33 8 (2006) 720-724
53. Peng X., Haldar S., Deshpande S., Irani K., and Kass D.A. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41 2 (2003) 378-381
54. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396 6708 (1998) 269-272
55. Dawes M., Sieniawska C., Delves T., Dwivedi R., Chowienczyk P.J., and Ritter J.M. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm. Circulation 105 11 (2002) 1323-1328
56. + channels (KIR) inhibits bradykinin-induced vasodilatation in human forearm resistance vasculature. Arterioscler Thromb Vasc Biol 25 2 (2005) e7-e9
57. Bussemaker E., Popp R., Binder J., Busse R., and Fleming I. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery. Kidney Int 63 5 (2003) 1749-1755
58. Bussemaker E., Wallner C., Fisslthaler B., and Fleming I. The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery. Br J Pharmacol 137 5 (2002) 647-654
59. Oberleithner H., Riethmuller C., Schillers H., MacGregor G.A., de Wardener H.E., and Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A 104 41 (2007) 16281-16286
60. Li J., White J., Guo L., et al. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 139 3 (2009) 447-451
61. Oberleithner H., Callies C., Kusche-Vihrog K., et al. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci U S A 106 8 (2009) 2829-2834
62. Safar M.E., and Boudier H.S. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension 46 1 (2005) 205-209
63. Buyck J.F., Blacher J., Kesse-Guyot E., et al. Differential associations of dietary sodium and potassium intake with blood pressure: a focus on pulse pressure. J Hypertens 27 6 (2009) 1158-1164
64. Machnik A., Neuhofer W., Jantsch J., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15 5 (2009) 545-552
65. Heer M., Baisch F., Kropp J., Gerzer R., and Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 278 4 (2000) F585-F595
66. Titze J., Maillet A., Lang R., et al. Long-term sodium balance in humans in a terrestrial space station simulation study. Am J Kidney Dis 40 3 (2002) 508-516
67. Titze J., Bauer K., Schafflhuber M., et al. Internal sodium balance in DOCA-salt rats: a body composition study. Am J Physiol Renal Physiol 289 4 (2005) F793-F802
68. Ziomber A., Machnik A., Dahlmann A., et al. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats. Am J Physiol Renal Physiol 295 6 (2008) F1752-F1763
69. Leonard A.M., Chafe L.L., Montani J.P., and Van Vliet B.N. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens 19 12 (2006) 1264-1269
70. Manchester R.C. The diurnal rhythm in water and mineral exchange. J Clin Invest 12 6 (1933) 995-1008
71. Wesson Jr. L.G., and Lauler D.P. Diurnal cycle of glomerular filtration rate and sodium and chloride excretion during responses to altered salt and water balance in man. J Clin Invest 40 (1961) 1967-1977
72. Stanbury S.W., and Thomson A.E. Diurnal variation in electrolyte excretion. Clin Sci (Lond) 10 3 (1951) 267-293
73. Dyer A.R., Martin G.J., Burton W.N., Levin M., and Stamler J. Blood pressure and diurnal variation in sodium, potassium, and water excretion. J Hum Hypertens 12 6 (1998) 363-371
74. Goldman R. Studies in diurnal variation of water and electrolyte excretion; nocturnal diuresis of water and sodium in congestive cardiac failure and cirrhosis of the liver. J Clin Invest 30 11 (1951) 1191-1199
75. Gumz M.L., Stow L.R., Lynch I.J., et al. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest 119 8 (2009) 2423-2434